LncRNA H19 Upregulation Participates in the Response of Glioma Cells to Radiation

Biomed Res Int. 2021 May 31:2021:1728352. doi: 10.1155/2021/1728352. eCollection 2021.

Abstract

Previous studies have indicated that radiation resistance of glioma is one of the leading causes of radiotherapy failure. Mounting evidence suggests that long non-coding RNA (lncRNA) plays an important role in regulating radiosensitivity of cancer cells via implicating in various cell processes. However, the underlying mechanisms remain unclear and need further study, especially at the molecular level. We found that the expression level of lncRNA H19 was elevated by radiation, and then, the modulation of H19 affected the resistant of glioma cells to X-rays. Dual-luciferase reporter analyses showed that H19 was transcriptionally activated by CREB1 in glioma cells after irradiation. In addition, both flow cytometry and 5-ethynyl-2'-deoxyuridine (EdU) assay suggested that H19 was involved in the cell cycle arrest, apoptosis, and DNA synthesis to modulate the radiation response of glioma cells and influenced their radioresistance. Therefore, H19 might play a crucial role in enhancing the radioresistance of glioma.

MeSH terms

  • Apoptosis
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / radiotherapy*
  • Cell Cycle
  • Cell Line, Tumor
  • Computational Biology
  • Cyclic AMP Response Element-Binding Protein / biosynthesis
  • DNA / metabolism
  • Gene Expression Regulation, Neoplastic*
  • Glioma / genetics*
  • Glioma / radiotherapy*
  • HEK293 Cells
  • Humans
  • Kaplan-Meier Estimate
  • RNA, Long Noncoding / biosynthesis*
  • RNA, Long Noncoding / genetics
  • Radiotherapy
  • Up-Regulation*
  • X-Rays

Substances

  • CREB1 protein, human
  • Cyclic AMP Response Element-Binding Protein
  • H19 long non-coding RNA
  • RNA, Long Noncoding
  • DNA